05.12.2022 - - The program will allow physicians to request access to TransCon PTH, the company’s investigational parathyroid hormone replacement therapy, for eligible patients in the United States - TransCon PTH is under Priority Review by the FDA, with a . Seite 1
Peggy Lillis Foundation and Ferring Pharmaceuticals Partner to Support Patients with C. difficile Infection
Share Article
Peggy Lillis Foundation for C. diff Education & Advocacy (PLF), the leading patient organization combating C. difficile infections (CDI), partners with Ferring Pharmaceuticals through a new sponsorship to help fund new and existing patient advocacy initiatives. Joining forces, PLF and Ferring are eager to continue helping people living with CDI and their loved ones.
PLF Stacked Logo
We are incredibly grateful for Ferring’s generous sponsorship as well as its ongoing partnership in the fight against CDI. BROOKLYN, N.Y. (PRWEB) March 11, 2021 Peggy Lillis Foundation for C. diff Education & Advocacy (PLF), the leading patient organization combating C. difficile infections (CDI), partners with Ferring Pharmaceuticals through a new sponsorship to help fund new and existing patient advocacy init